fbpx

Publications

welcome to the Publication directory

A new approach methodology (NAM) for the prediction of (nor)ibogaine-induced cardiotoxicity in humans

Miaoying Shi, Sebastiaan Wesseling, Hans Bouwmeester and Ivonne M. C. M. Rietjens
July 2021

A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder

Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua L, Glasgow AM, Brallier J, Pietrzak RH, Murrough JW, Charney DS
February 2021

A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats

Paola Rodrı Guez, Jessika Urbanavicius, José Pedro Prieto, Sara Fabius, Ana Laura Reyes, Vaclav Havel, Dalibor Sames, Cecilia Scorza, Ignacio Carrera
May 2020

A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus

Rafael Vitor Lima da Cruz, Thiago C. Moulin, Lyvia Lintzmaier Petiz, and Richardson N. Leão
September 2018

A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial

Elias Dakwar, Frances Levin, Carl L Hart, Cale Basaraba, Jean Choi, Martina Pavlicova, Edward V Nunes
February 2020

Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression

Steven Pennybaker, Brian J. Roach, Susanna L. Fryer, Anusha Badathala, Art W. Wallace, Daniel H. Mathalon & Tobias F. Marton
August 2021

Anti-inflammatory and analgesic actions of bufotenine through inhibiting lipid metabolism pathway

Jiaojiao Wang, Dihui Xu, Lili Shen, Jing Zhou, Xiang Lv, Hongyue Ma, Nianguang Li, Qinan Wu, Jinao Duan
August 2021

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression

Wilkowska A, Wiglusz MS, Gałuszko-Wegielnik M, Włodarczyk A, Cubała WJ.
October 2021

Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers

Jerome Sarris, Daniel Perkins, Lachlan Cribb, Violeta Schubert, Emerita Opaleye, José Carlos Bouso, Milan Scheidegger, Helena Aicher, Hana Simonova, Miroslav Horák, Nicole Leite Galvão-Coelho, David Castle, Luís FernandoTófoli
April 2021

Ceremonial Ayahuasca in Amazonian Retreats—Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study

Simon G. D. Ruffell, Nige Netzband, WaiFung Tsang, Merlin Davies, Matthew Butler, James J. H. Rucker, Luís Fernando Tófoli, Emma Louise Dempster, Allan H. Young, Celia J. A. Morgan
June 2021

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Lindsay P. Cameron, Charlie J. Benson, Brian C. DeFelice, Oliver Fiehn, and David E. Olson
March 2019

Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial

Samuel T Wilkinson, DaShaun Wright, Madonna K Fasula, Lisa Fenton, Matthew Griepp, Robert B Ostroff, Gerard Sanacora
May 2017

Combining Ketamine and Internet-Based Cognitive Behavioral Therapy for the Treatment of Posttraumatic Stress Disorder: Protocol for a Randomized Controlled Trial

Aaron Emile Philipp-Muller, BSc, Taras Reshetukha, MD, FRCPC, Gustavo Vazquez, MD, PhD, FRCPC, Roumen Milev, MD, PhD, FRCPC, Dawn Armstrong, BSc, Jasleen Jagayat, BSc, and Nazanin Alavi, MD, FRCPC
July 2021

Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers

Juliana Mendes Rocha, Giordano Novak Rossi, Flávia L. Osório, José Carlos Bouso Saiz, Gabriela De Oliveira Silveira, Mauricio Yonamine, Eduardo José Crevelin, Maria Eugênia Queiroz, Jaime E. Cecílio Hallak and Rafael Guimarães Dos Santos
August 2021

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

Davis, A,K., Barrett, F.S., Darrick G. May, D.G., Cosimano, M.P., Sepeda, N.D., Johnson, M.W., Finan, P.H., & Griffiths, R.R.
November 2020

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

Alan K Davis, Frederick S Barrett, Darrick G May, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Patrick H Finan, Roland R Griffiths
May 2021

Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial

Jennifer B Dwyer, Angeli Landeros-Weisenberger, Jessica A Johnson, Amalia Londono Tobon, José M Flores, Madeeha Nasir, Kevin Couloures, Gerard Sanacora, Michael H Bloch
April 2021

Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review

Jason Ng, Joshua D Rosenblat, Leanna M W Lui, Kayla M Teopiz, Yena Lee, Orly Lipsitz, Rodrigo B Mansur, Nelson B Rodrigues, Flora Nasri, Hartej Gill, Danielle S Cha, Mehala Subramaniapillai, Roger C Ho , Bing Cao, Roger S McIntyre
October 2021

Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test

Mark Molumby, Keith Gaynor, Suzanne Guerin
November 2021

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin

Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher H. Gottschalk, Christina Luddy, L. Taylor Flynn, Hayley Lindsey, Brian P. Pittman, Nicholas V. Cozzi & Deepak C. D’Souza
November 2020

Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder

Richard J. Zeifman, Anne Wagner
January 2020

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder

Ben Sessa, Laurie Higbed, Steve O'Brien, Claire Durant, Chloe Sakal, Daniel Titheradge, Tim M Williams, Anna Rose-Morris, Elsa Brew-Girard, Sam Burrows, Chantelle Wiseman, Sue Wilson, James Rickard, David J Nutt
April 2021

Four Weekly Ayahuasca Sessions Lead to Increases in “Acceptance” Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program

Joaquim Soler, Matilde Elices, Elisabeth Dominguez-Clavé, Juan C. Pascual, Amanda Feilding, Mayte Navarro-Gil, Javier García-Campayo, and Jordi Riba
March 2018

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes

Deborah C. Mash, Linda Duque, Bryan Page, and Kathleen Allen-Ferdinand
June 2018

Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color

Alan K. Davis, Yitong Xin, Nathan D. Sepeda, Albert Garcia-Romeu, Monnica T. Williams
August 2021

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments

Kyle T. Greenway , Nicolas Garel , Lisa Jerome & Allison A. Feduccia
June 2020

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments

Kyle T Greenway, Nicolas Garel, Lisa Jerome, Allison A Feduccia
June 2020

Ketamine and depression: a narrative review

Alexandrine Corriger, Gisèle Pickering
August 2019

Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review

Johanna Louise Keeler, Janet Treasure, Mario F. Juruena, Carol Kan, Hubertus Himmerich
November 2021

Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial

Yoav Domany, Richard C Shelton, Cheryl B McCullumsmith
October 2019

Long-term Follow-up of Psilocybin-facilitated Smoking Cessation

Matthew W. Johnson, PhD, Albert Garcia-Romeu, PhD, and Roland R. Griffiths, PhD
July 2016

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials

Lisa Jerome, Allison A. Feduccia, Julie B. Wang, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Michael C. Mithoefer, Rick Doblin
June 2020

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission

Danilo De Gregorio, Jelena Popic, Justine P. Enns, Antonio Inserra, Agnieszka Skalecka, Athanasios Markopoulos, Luca Posa, Martha Lopez-Canul, He Qianzi, Christopher K. Lafferty, Jonathan P. Britt, Stefano Comai, Argel Aguilar-Valles, Nahum Sonenberg, and Gabriella Gobbi
February 2021

Lysergic Acid Diethylamide Induces Increased Signalling Entropy in Rats’ Prefrontal Cortex

Aurora Savino, Charles D. Nichols
November 2021

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review

Gniewko Więckiewicz, Iga Stokłosa, Magdalena Piegza, Piotr Gorczyca and Robert Pudlo
August 2021

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

Philip E. Wolfson, Julane Andries, Allison A. Feduccia, Lisa Jerome, Julie B. Wang, Emily Williams, Shannon C. Carlin, Evan Sola, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Michael C. Mithoefer & Rick Doblin
November 2020

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin
May 2019

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Jennifer M. Mitchell,Michael Bogenschutz, Rick Doblin
May 2021

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches

Albert Garcia-Romeu, Frederick S Barrett, Theresa M Carbonaro, Matthew W Johnson, Roland R Griffiths
February 2021

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences

Monnica T. Williams,Alan K. Davis,Yitong Xin,Nathan D. Sepeda,Pamela Colón Grigas,Sinead Sinnott & Angela M. Haeny
Dec 2020 10

Pharmacodynamic interactions between ketamine and psychiatric medications used in the treatment of depression: a systematic review

Jolien K E Veraart, MD, Sanne Y Smith-Apeldoorn, MD, Iris M Bakker, BSc, Berber A E Visser, BSc, Jeanine Kamphuis, MD, PhD, Robert A Schoevers, MD, PhD, Daan J Touw, PharmD
June 2021

Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa

Sarah-Catherine Rodan, Phillip Aouad, Iain S McGregor, Sarah Maguire
June 2021

Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo

Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A. Davoudian, Neil K. Savalia, Kristina Delagarza, Alex C.Kwan
July 2021

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

R L Carhart-Harris,, M Bolstridge, C M J Day, J Rucker, R Watts, D E Erritzoe, M Kaelen, B Giribaldi, M Bloomfield, S Pilling, J A Rickard, B Forbes, A Feilding, D Taylor, H V Curran, D J Nutt
November 2017

Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience

Martin K. Madsen, Dea S.Stenbæk, Albin Arvidsson, Sophia Armanda Maja R.Marstrand-Joergensen, Sys S. Johansen, Kristian Linnet, Brice Ozenne, Gitte M.Knudsen, Patrick M. Fisher
September 2021

Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors

Robertas Strumila, Bénédicte Nobile, Laura Korsakova, Aiste Lengvenyte, Emilie Olie, Jorge Lopez-Castroman, Sébastien Guillaume, Philippe Courtet
November 2021

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness

H. Kettner, F. E. Rosas, C. Timmermann, L. Kärtner, R. L. Carhart-Harris, and L. Roseman
March 2021

Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans

Alan K. Davis, Lynnette A. Averill, Nathan D. Sepeda, Joseph P. Barsuglia, Timothy Amoroso
July 2020

Psychedelic-Assisted Group Therapy: A Systematic Review

Alexander Trope, Brian T. Anderson, Andrew R. Hooker, Giancarlo Glick, Christopher Stauffer, Joshua D. Woolley
April 2019

Psychedelic-Inspired Approaches for Treating Neurodegenerative Disorders

Hannah N Saeger, David E Olson
November 2021